Versameb AG Achieves the First Patent in China for Signal Peptide Technology Versameb AG celebrates a key patent grant in China for its innovative signal peptide tech, enhancing RNA therapeutics. This milestone paves the way for advancements in medical treatments.

Versameb AG Achieves the First Patent in China for Signal Peptide Technology #Switzerland #RNA_Therapeutics #Basel #Versameb #signal_peptides